SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 196.08-0.2%Jan 15 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kash Khorasani who wrote (15041)2/13/1998 11:48:00 PM
From: John Zwiener  Read Replies (1) of 32384
 
Kash and Henry, I've noticed this before and was now reminded of it. There is a phase 2 study on actinic keratosis (premalignant skin lesions from too much sun exposure). This now becoming a massive problem for those many people who played, and worked, outside without a hat (remember, those went out with the 60's) or adequate clothing to protect themselves from the sun. Also, people are living longer. This is a large population and the only treatment that works, sort of, is 5FU, a very irritating agent. 5 fluorouracil has a limited effect and breakthoughs are common with many skin CAs. This phase 2 trial is worth watching as well as the other big ones.

Any info on how this one is doing and when is it due?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News